DCN and Peritoneal Fibrosis: Intraperitoneal administration of plasmid DNA expressing decorin with gold nanoparticles inhibited peritoneal fibrosis by inhibiting the effects of TGF-β1 in a rat peritoneal fibrosis model [37].